2-(2-Bromo-4-fluorophenyl)-1,3-dioxolane, 95+%, 250mg

(2E)-1-(4-ethoxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one, 95.0%, 10g

4-(Chloromethyl)-5-methylisoxazole, 95.0%, 250mg

1,3,5-Triazine-2,4-diamine, 6-(2,5-dichlorophenyl)-, 98%, 250mg

3-(3-FLUORO-4-NITROPHENYL)PYRIDINE, 95.0%, 100mg

BMPyrr TFSI, 25 g, >=99%, emballage en verre

7-Bromo-3-oxoisoindoline-4-carbonitrile, 98%, 100mg

(1-(tert-Butoxycarbonyl)-1,2,3,6-tetrahydropyridin-4-yl)boronic acid, 95.0%, 5g

Colonne Vigreux avec coque en verre, 600 mm, 1 pièce

Na-Methyl-L-lysine hydrochloride, 95.0%, 1g

2-hydroxy-N-(pyridin-3-ylmethyl)benzamide, 5g

2-Bromopriopionaldehydediethylacetal, 95.0%, 1g

(3AR,6R,6AR)-6-(((TERT-BUTYLDIMETHYLSILYL)OXY)METHYL)-2,2-DIMETHYLDIHYDROFURO[3,4-D][1,3]DIOXOL-4(3AH)-ONE, 95.0%, 2g